早期卵巢癌淋巴結摘除的檢視

The role of lymphadenectomy for early-stage ovarian cancer patients

全部後腹膜淋巴結摘除可以準確性作為卵巢癌的分期，根據國際婦產科醫學會指引，目前對早期（第I－II期）卵巢癌仍建議做後腹膜淋巴廓清，然此手術會有較多的副作用。最近文獻回顧顯示，除後腹膜有明顯腫大淋巴結需要摘除，作為減積手術的一部份之外，其餘正常大小的淋巴結是無需摘除的。

Systematic retroperitoneal lymphadenectomy is necessary to accurately determine the stages for ovarian cancer. According to the current guidelines of the International Federation of Gynecology and Obstetrics (FIGO), the removal of both pelvic and paraaortic lymph nodes during surgery is still a recommended procedure for apparent early stage (FIGO I and II) epithelial ovarian cancers. However, the therapeutic significance of systematic lymphadenectomy for patients with early-stage ovarian cancer is a matter of great debate. On the other hand, systematic lymphadenectomy may increase surgical morbidity, although it is necessary for accurate clinical staging and has diagnostic valus. After literature review, it seems to be state that systematic lymphadenectomy in patients with early ovarian is not necessary, and the presence of macroscopic retroperitoneal retroperitoneal lymph nodes should be resected as part of cytoreductive surgery. We present an extensive review of the available literature on the matter, hoping to provide some insight into the true need for such a procedure.